ReviewCell biochemistry and biophysics2025
Innovative Nanotechnology and Molecular Probes for Real-time Monitoring and Therapeutic Modulation of Pyroptosis in Cancer and Inflammatory Diseases.
Review in Cell biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy.Journal of Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pyroptosis is a recently identified form of programmed cell death that plays a crucial role in tumor development and immune regulation. It provides various novel perspectives on prognostic markers and possible therapeutic approaches. Unlike necrosis and apoptosis, pyroptosis, is characterized by the activation of pore-forming protein called gasdermin D (GSDMD), which is cleaved by caspase enzymes to form oligomers that disrupt the cell membrane, leading to rapid cell lysis. The interaction between pyroptosis and immunotherapy presents promising opportunities to enhance cancer treatments and improve patient outcomes. However, despite extensive research, the underlying mechanisms of pyroptosis are not yet fully understood. Recent advancements have focused on noninvasive and real-time imaging techniques to elucidate pyroptosis dynamics at the molecular level. This review comprehensively discusses innovative monitoring strategies, including molecular probes, nanotechnology-based tools, and computational approaches, which provide valuable insights into pyroptosis regulation. By leveraging these advanced methodologies, researchers can refine therapeutic strategies, paving the way for more effective and personalized treatments for cancer and inflammatory diseases.
Indexed as
Identifiers
40888825What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.